Furthermore, levels of p-ERK, VEGF, and HIF-α were reduced by curcumin in liver cancer cells the same way they were reduced in IGF-1R-knockout liver cancer cells, suggesting that curcumin suppresses tumour progression in an IGF-1R-dependent manner involving the MAPK pathway (Chen et al., 2018). The gene discussed is IGF1R; the disease is liver cancer.